Daiichi Sankyo Seeks FDA Approval Of WelChol With Zetia
This article was originally published in The Pink Sheet Daily
Executive Summary
Japanese firm files data with FDA showing efficacy of WelChol with ezetimibe in reducing LDL cholesterol.
You may also be interested in...
Daiichi Sankyo Eyes U.S. Expansion With Major Sales Force Boost
The Japanese pharma looks to more than double existing U.S. sales force in anticipation of rapid growth.
Daiichi Sankyo Submits WelChol sNDA For Diabetes Indication
If approved, WelChol would be the first LDL-lowering therapy also approved for improving glycemic control.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.